Skip to main content
SpringerLink
Log in

Multimodal strategy in locally advanced inoperable head and neck cancer : A pilot study

  • Short Communication
  • Published:
Indian Journal of Otolaryngology and Head and Neck Surgery Aims and scope Submit manuscript

Abstract

Squamous cell carcinoma of the Head and Neck is the commonest cancer at our centre and the majority were in locally advanced inoperable stage (stage III and IV) where surgery and/or radiotherapy were able to cure less than 10% of the patients. This study was conducted to determine the role of neo-adjuvant chemotherapy in these cases and to bring locally advanced inoperable disease within perview of surgery and/ or curative radiotherapy. A total of 32 patients found inoperable or unsuitable for curative radiotherapy were treated with neoadjuvant chemotherapy (Cisplatinum, 5FU, Bleomycin and Hydroxyurea × 3 cycles) followed by surgery and or radiotherapy. All the patients were evaluable for response. An objective response rate following neoadjuvant chemotherapy was 81% (28% CR, 53% PR). Subsequent surgery or radiotherapy were able to have 56.25% (18/32) of patients disease free at 4 years with overall survival 46.8% at 4 years. Neoadjuvant chemotherapy along with radiotherapy and/or surgery might be an effective protocol in controlling advanced inoperable head and neck squamous cell carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Al-Kouraint K, Crissman J, Ensley J, Kish J, Kelly J, Al-Sarraf M. (1988): Excellent response to cisplatinum-based chemotherapy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma.American journal of Clinical Oncology 11; 427–430.

    Article  Google Scholar 

  2. Dasmahapatra KS, Citrin P., Hill GJ, Yee R, Mohit-Tabatabai MA, BF Jr. (1985): A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.Journal of Clinical Oncology 3; 1486–1489.

    PubMed  CAS  Google Scholar 

  3. Deitmber T., Urbanitz D., Zytostatische Primartherapie von Plattemepithel-Karzinomen des (1986): Oro- and Hypopharynx mit Cisplatin, Bleomycin un Methotrexate Laryngology Rhinology Otology (Stuttg); 65;7–10.

    Google Scholar 

  4. Fountazilas G, Daniilidis J, Sridhar Ks, Fountzil Ed, Vritsios A, Tourkantonis A, (1990): Induction chemotherapy with a new regimen alternating Cisplatin, Fluorouracil with Mitomycin, Hydroxyurea and Bleomycin in Carcinomas of Nasopharynx or other sites of the head and neck region. cancer 66; 1453–1460.

    Google Scholar 

  5. Hermanek. P, Sobin LH. TNM classification of Malignant Tumors. 4th Ed., Springer Verlog, page. 17–25.

  6. Kish JA., Weaver A, Jacobs J., Cummings G, Al-Saraf M. (1984): Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck, Cancer 53; 1819–1824.

    Article  PubMed  CAS  Google Scholar 

  7. Kish JA, Ensley JF, Jacobs J, Weaver A, Cummings G, Al-Saraf M. (1985): A randomized trial of cisplatin + 5-fluorouracil infusion and CACP + 5-FU bolus for recurrent an advanced squamous cell carcinoma of the head and neck, Cancer 56; 2740–2744.

    Article  PubMed  CAS  Google Scholar 

  8. Merino OR, Lindberg RD, Fletcher GH. (1977): An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40; 145–151.

    Article  PubMed  CAS  Google Scholar 

  9. Paredes J, Hong WK, Felder TB et al. (1988): Prospective randomized trial of highdose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Journal of Clinical Oncology 6; 955–962.

    PubMed  CAS  Google Scholar 

  10. Rooney M, Kish J, Jacobs J et al. (1985): Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 55; 1123–1128.

    Article  PubMed  CAS  Google Scholar 

  11. Rozencweing M, Dodion P, Bruntsch U et al. (1984): Combination chemotherapy with Cisplatin methotrexate, bleomycin and Vincristine in advanced squamous cell carcinoma of the head and neck Cancer 54; 1499–1503.

    Article  Google Scholar 

  12. Sridhar KS, Ohnuma T, Biller H et al. (1985): Combination chemotherapy with high dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma. American Journal of Clinical Oncology 8: 55–60.

    Article  PubMed  CAS  Google Scholar 

  13. Thyss A, Milano G, Renne N, et al. (1986): Clinical pharmacokinetic study of 5-FU in continuous 5-day infusion for head and neck cancer. Cancer Chemotherapy Pharmacology 16; 64–66.

    CAS  Google Scholar 

  14. Vikram B, Strong EW, Shah JP et al. (1984): Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surgery 6; 730–733.

    Article  PubMed  CAS  Google Scholar 

  15. Vogl SE, Schoenfeld DA, et al. (1985): Randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer. Cancer 56, 432–442.

    Article  PubMed  CAS  Google Scholar 

  16. Vokes EE, Choi KE, Schilsky RL et al. (1988): Cisplatin, fluorouracil, and high dose leucovorin for recurrent or metastatic head and neck cancer. Journal of Clinical Oncology 6; 618–626.

    PubMed  CAS  Google Scholar 

  17. Weichselbaum RR, Clark Jr, et al. (1985): Combined modality treatment of head and neck cancer with cisplatinum, bleomycin, methotrexate leucovorin chemotherapy. Cancer 55; 2149–2155.

    Article  PubMed  CAS  Google Scholar 

  18. Williams SD, Velez-Garcia E et al. (1986): Chemotherapy for head and neck cancer : Comparison of cisplatinum + vinblastin + bleomycin versus methotrexate. Cancer 57; 18–23.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology, Cancer Hospital & Research Institute, Gwalior (M.P.), India

    Narendra Deo

  2. Cancer Hospital & Research Institute, Gwalior (M.P.), India

    M. K. Gupta, B. R. Shrivastava & K. K. Agrawal

Authors
  1. Narendra Deo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. K. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. R. Shrivastava
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. K. Agrawal
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deo, N., Gupta, M.K., Shrivastava, B.R. et al. Multimodal strategy in locally advanced inoperable head and neck cancer : A pilot study. IJO & HNS 48, 327–330 (1996). https://doi.org/10.1007/BF03048673

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03048673

Keywords

Search

Navigation